These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 16280054

  • 1. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
    van Wezel T, Lombaerts M, van Roon EH, Philippo K, Baelde HJ, Szuhai K, Cornelisse CJ, Cleton-Jansen AM.
    Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
    [Abstract] [Full Text] [Related]

  • 2. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
    Green AR, Krivinskas S, Young P, Rakha EA, Paish EC, Powe DG, Ellis IO.
    Breast Cancer Res Treat; 2009 Jan; 113(1):59-66. PubMed ID: 18213475
    [Abstract] [Full Text] [Related]

  • 3. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI, Minna JD.
    Cancer Res; 2000 Nov 01; 60(21):6116-33. PubMed ID: 11085536
    [Abstract] [Full Text] [Related]

  • 4. Chromosome 16 tumor-suppressor genes in breast cancer.
    Rakha EA, Green AR, Powe DG, Roylance R, Ellis IO.
    Genes Chromosomes Cancer; 2006 Jun 01; 45(6):527-35. PubMed ID: 16518845
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J, Flanagan J, Phillips WA, Chenevix-Trench G, Arnold J.
    Br J Cancer; 2003 Jan 27; 88(2):270-6. PubMed ID: 12610513
    [Abstract] [Full Text] [Related]

  • 6. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M, McKenzie OL, Bais AJ, Martin JM, Secker GA, Seshadri R, Powell JA, Hinze SJ, Gardner AE, Spendlove HE, O'Callaghan NJ, Cleton-Jansen AM, Cornelisse C, Whitmore SA, Crawford J, Kremmidiotis G, Sutherland GR, Callen DF.
    Cancer Res; 2002 Aug 15; 62(16):4599-604. PubMed ID: 12183414
    [Abstract] [Full Text] [Related]

  • 7. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S, Becker KF, Braungart E, Reichmuth C, Klamt B, Becker I, Atkinson M, Gessler M, Höfler H.
    J Pathol; 2000 Jun 15; 191(2):162-9. PubMed ID: 10861576
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.
    Rakha EA, Pinder SE, Paish CE, Ellis IO.
    Br J Cancer; 2004 Oct 18; 91(8):1591-6. PubMed ID: 15354217
    [Abstract] [Full Text] [Related]

  • 10. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
    Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V, Ingvarsson S.
    Br J Cancer; 1999 Dec 18; 81(7):1103-10. PubMed ID: 10584868
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, Mccallum B, Crawford J, Powell JA, Settasatian C, van Beerendonk H, Moerland EW, Smit VT, Harris WH, Millis R, Morgan NV, Barnes D, Mathew CG, Cornelisse CJ.
    Cancer Res; 2001 Feb 01; 61(3):1171-7. PubMed ID: 11221848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Rougé C, Ursule L, Nguyen C, Bibeau F, Rodriguez C, Theillet C.
    Br J Cancer; 2006 Nov 20; 95(10):1439-47. PubMed ID: 17060936
    [Abstract] [Full Text] [Related]

  • 16. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, Lo PH, Stanbridge EJ, Tang JC, Srivastava G, Tsao SW, Law S, Lung ML.
    Mol Cancer Res; 2008 Apr 20; 6(4):592-603. PubMed ID: 18403638
    [Abstract] [Full Text] [Related]

  • 17. The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma.
    Lin YW, Yan MD, Shih YL, Hsieh CB.
    Eur J Cancer; 2009 Jul 20; 45(11):2041-9. PubMed ID: 19410446
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
    Presneau N, Dewar K, Forgetta V, Provencher D, Mes-Masson AM, Tonin PN.
    Mol Carcinog; 2005 Jul 20; 43(3):141-54. PubMed ID: 15937959
    [Abstract] [Full Text] [Related]

  • 19. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23.
    Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS.
    Genes Chromosomes Cancer; 2005 May 20; 43(1):95-103. PubMed ID: 15672406
    [Abstract] [Full Text] [Related]

  • 20. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
    Cleton-Jansen AM, Buerger H, Haar Nt, Philippo K, van de Vijver MJ, Boecker W, Smit VT, Cornelisse CJ.
    Genes Chromosomes Cancer; 2004 Oct 20; 41(2):109-16. PubMed ID: 15287023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.